Evidence map›Paper›PMID 37751045›Full record

ArticleGeroScience2024

Bleomycin-treated myoblasts undergo p21-associated cellular senescence and have severely impaired differentiation.

Michael Kamal, Sophie Joanisse, Gianni Parise

Open access · greenAbstract read
In one paragraph

Article in GeroScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Behavioral and Functional Profiling ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Hesperetin Alleviates Bleomycin-Induced Pulmonary Fibrosis by Modulating Cellular Senescence and Promoting Impaired Autophagy in a CISD2-Dependent Manner.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Article
  6. Emerging Roles of Vitamin BInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Michael KamalExercise Metabolism Research Group, Department of Kinesiology, McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-3055-6793
Sophie JoanisseExercise Metabolism Research Group, Department of Kinesiology, McMaster University, Hamilton, ON, Canada.ORCID 0000-0001-9983-9401
Gianni PariseExercise Metabolism Research Group, Department of Kinesiology, McMaster University, Hamilton, ON, Canada. pariseg@mcmaster.ca.ORCID 0000-0002-0272-1528
McMaster University · CAManchester Metropolitan University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As we age, the ability to regenerate and repair skeletal muscle damage declines, partially due to increasing dysfunction of muscle resident stem cells-satellite cells (SC). Recent evidence implicates cellular senescence, which is the irreversible arrest of proliferation, as a potentiator of SC impairment during aging. However, little is known about the role of senescence in SC, and there is a large discrepancy in senescence classification within skeletal muscle. The purpose of this study was to develop a model of senescence in skeletal muscle myoblasts and identify how common senescence-associated biomarkers respond. Low-passage C

Indexed as

BleomycinCellular SenescenceBiomarkersCell DifferentiationCell LineMyoblastsBiomarkersBleomycinAgingBleomycinMyoblastSenescenceSkeletal muscle

Identifiers

PMID37751045
PMCPMC10828175
OpenAlexW4387033156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.